GlassScriptPhysician profile
Thieu Nguyen
NPI 1609967165
$5,413.01
in general payments reported to CMS, 2019-2025
17 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $80.98 · 2021: $578 · 2022: $625 · 2023: $2,817 · 2024: $817 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990 · Travel and Lodging: $1,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.90 |
| Travel and Lodging | $1,935.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,552.90 | 2020-2025 | Watchman Access System, Watchman Flx, Latitude Communicator Power Supply |
| Janssen Pharmaceuticals, INC | $944.69 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $381.99 | 2019-2024 | Eliquis, Camzyos |
| Abbott Laboratories | $299.40 | 2022-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $269.11 | 2021-2023 | Farxiga |
| Abiomed | $148.62 | 2024 | Impella |
| Gilead Sciences, INC. | $124.92 | 2024 | Vemlidy |
| Aimmune Therapeutics, INC. | $124.91 | 2025 | Zenpep |
| Glaxosmithkline, LLC. | $123.63 | 2024 | Arexvy |
| Pfizer INC. | $119.36 | 2019-2024 | |
| Dexcom, INC. | $116.81 | 2024 | Dexcom G7 Gss (161) |
| Amgen INC. | $85.43 | 2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $30.65 | 2025 | |
| Scpharmaceuticals INC. | $29.06 | 2025 | |
| Novartis Pharmaceuticals Corporation | $24.00 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $20.16 | 2024 | Acthar |
| Bard Peripheral Vascular, INC. | $17.37 | 2024 | Venclose Maven Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thieu Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.